Hims vs Found: GLP-1 Weight Loss Programs Compared (2026)
An independent, side-by-side comparison of Hims and Found for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Found
Starting at $149/mo vs $199/mo
Most Medications
Hims
2 medications vs 2
Best for Beginners
Hims
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Hims | Found | Savings |
|---|---|---|---|
| Semaglutide | $199/monthly | $149/monthly | Save $50/mo with Found |
| Tirzepatide | $399/monthly | $399/monthly | Similar pricing |
Pros and Cons
Hims
- Publicly traded company with financial transparency
- Massive scale — millions of customers across health verticals
- Both compounded and brand-name options
- Free provider consultations included
- No video consultations
- No lab testing included
- GLP-1 only — no other peptides
- Compounded medication availability may vary by state
Found
- Holistic approach — medication + coaching + community
- Board-certified obesity medicine specialists
- Competitive compounded semaglutide pricing
- Personalized weight-loss plans with behavior change focus
- Slower shipping than competitors (5-7 days)
- No lab testing included
- Coaching quality can vary
- Limited to weight-loss medications only
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 14, 2026
Hims vs Found: GLP-1 Weight Loss Programs Compared
Hims (and its sister brand Hers for women) is a consumer wellness platform that added GLP-1 weight loss as one service among many. Found is a purpose-built weight management platform that uses a broad menu of medications — GLP-1 and non-GLP-1 — alongside behavioral coaching. Here is how they compare.
Quick Verdict
| Hims | Found | |
|---|---|---|
| Monthly cost | ~$199/month | ~$99–199/month |
| Best for | Simple GLP-1 access within a familiar brand; men's health context | Multi-medication flexibility; patients who want non-GLP-1 options |
| Medication options | Primarily semaglutide | GLP-1 + metformin, naltrexone-bupropion, phentermine, topiramate |
| Tirzepatide | Limited | Limited |
| Coaching | Basic | Personalized health coach |
| Insurance navigation | No | Limited |
| Start time | 5–10 days | 5–10 days |
Brand and Platform Context
Hims: Built as a men's health brand (with Hers for women) covering hair loss, ED, skincare, and mental health before adding weight management. Weight loss is a product line within a broader consumer health platform. The advantage: brand recognition and a single platform for multiple health needs. The limitation: weight management is not Hims' primary focus or deepest competency.
Found: Built exclusively for weight management from the start. The platform's entire clinical infrastructure — provider training, medication protocols, coaching model, and behavioral content — is organized around metabolic health and weight. Weight is what Found does, not one of several things it does.
Pricing
| Component | Hims | Found |
|---|---|---|
| Monthly program fee | ~$199/month | ~$99/month |
| Medication included | Yes (semaglutide) | Varies by medication prescribed |
| GLP-1 specifically | Included at $199 | Additional cost (total ~$199–249/month with GLP-1) |
| Non-GLP-1 medications | Not standard | Often lower cost; sometimes included |
| Insurance accepted | No | Limited |
Cost reality: Both platforms land near $199/month for GLP-1 access. Found's $99 base fee plus medication can match or exceed $199 depending on what's prescribed. For non-GLP-1 medications (metformin, phentermine), Found's total cost can be substantially lower.
Medication Flexibility: Found's Advantage
Found's multi-medication model is its most distinctive feature:
| Medication | Hims | Found |
|---|---|---|
| Compounded semaglutide | Yes | Yes |
| Tirzepatide (compounded) | Limited | Limited |
| Metformin | No | Yes |
| Naltrexone-bupropion (Contrave) | No | Yes |
| Phentermine | No | Yes |
| Topiramate | No | Yes |
| Combination protocols | No | Yes |
Who Found's breadth serves: Patients who can't tolerate GLP-1 side effects, who've tried semaglutide without adequate response, or who have specific comorbidities that make a non-GLP-1 medication more appropriate. Found can switch medications or combine protocols within the same platform.
Who Hims's simplicity serves: Patients who want semaglutide specifically and prefer a streamlined, brand-familiar experience.
Coaching and Program Structure
| Feature | Hims | Found |
|---|---|---|
| Personalized health coach | No | Yes |
| Behavioral curriculum | Limited | Structured |
| Nutrition guidance | Basic | Moderate |
| Check-in frequency | Async provider access | Regular coach + provider |
| App experience | Integrated with Hims app | Dedicated Found app |
| Community | No | Limited |
Found's coaching model is more robust — a dedicated health coach who tracks progress alongside medical provider oversight. Hims provides provider access and guidance but without the same dedicated coaching layer.
Men's Health Context (Hims Advantage)
For men specifically, Hims has an integration advantage: the Hims platform covers ED, hair loss, testosterone support, and mental health alongside weight management. Patients already using Hims for other health needs can add weight management without creating a new provider relationship.
This matters because: GLP-1-mediated weight loss in men with obesity often has secondary benefits for testosterone levels and sexual function. Having both managed in one platform has practical appeal for some patients.
Head-to-Head: Who Should Choose Which
Choose Hims if:
- You want semaglutide specifically with a familiar, consumer-friendly brand
- You're already using Hims for other health services
- You want a simple, integrated app experience
- GLP-1 is your definite medication choice
Choose Found if:
- You want access to non-GLP-1 medications or combination protocols
- You want a dedicated weight management platform vs a general wellness app
- GLP-1 side effects have been a problem and you want alternatives
- You want a personalized health coach as part of your program
- Cost flexibility matters — non-GLP-1 options may be cheaper
Alternatives to Consider
| Provider | Why Consider | Monthly Cost |
|---|---|---|
| Henry Meds | Fastest start, tirzepatide, $129 after 6 months | $149 |
| Ro | Clean, fast, tirzepatide + semaglutide | $149 |
| Noom Med | CBT behavioral curriculum alongside semaglutide | $149 |
| Hers | Women-specific equivalent to Hims | Similar to Hims |
Related Resources
- Best GLP-1 Without Insurance — cash-pay options ranked
- GLP-1 Alternatives FAQ — non-GLP-1 weight loss medications
- Found vs Henry Meds — Found vs another mid-tier platform
- Hims vs Ro — Hims vs its closest GLP-1 competitor
- How Much Weight Can You Lose on GLP-1 — realistic expectations
Related Guides
Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of March 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in March 2026. Here's what patients need to know and what to do.
Read guide →